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Abstract:  
Rationale. Men have poorer health status and are less likely to attend health screening 
compared to women.  
Objective. This systematic review presents current evidence on the barriers and facilitators to 
engaging men in health screening.  
Methods.  We included qualitative, quantitative and mixed-method studies identified through 
five electronic databases, contact with experts and reference mining. Two researchers 
selected and appraised the studies independently. Data extraction and synthesis were 
conducted using the ‘best fit’ framework synthesis method.  
Results. 53 qualitative, 44 quantitative and 6 mixed-method studies were included. Factors 
influencing health screening uptake in men can be categorized into five domains: individual, 
social, health system, healthcare professional and screening procedure. The most commonly 
reported barriers are fear of getting the disease and low risk perception; for facilitators, they 
are perceived risk and benefits of screening. Male-dominant barriers include heterosexual -
self-presentation, avoidance of femininity and lack of time. The partner's role is the most 
common male-dominant facilitator to screening.  
Conclusions. This systematic review provides a comprehensive overview of barriers and 
facilitators to health screening in men including the male-dominant factors. The findings are 
particularly useful for clinicians, researchers and policy makers who are developing 
interventions and policies to increase screening uptake in men.  
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Introduction 
Globally, men do not live as long as women (Barford et al., 2006; WHO, 2011) and 
have higher mortality and morbidity rates across most of the diseases (AIHW, 2013; Bilsker 
et al., 2010; EC, 2011; Ng et al., 2014; White et al., 2011a). Possible explanations include 
men’s poor health seeking behavior, lack of health knowledge, risk taking behavior as well as 
their reluctance to engage in health promotion activities (Addis & Mahalik, 2003; Byrnes et 
al., 1999; Courtenay, 2003).  
Various strategies can be used to improve the status of men’s health, particularly 
health screening. Through health screening, one can identify a disease at the early stage 
allowing intervention before the disease worsens. For instance, a study on the impact of 
cardiovascular disease (CVD) screening reported that screening attenders have lower CVD 
mortality rate, all-cause mortality rate, healthcare utilization and cost compared to non-
attenders (Lee et al., 2015). A one percent reduction of cardiovascular events through a 
preventive program across England and Wales has the potential to save at least £30 million of 
health services cost per year (Barton et al., 2011). Similarly, screening for colorectal cancer 
using faecal occult blood test (FOBT) was reported to decrease the relative risk of colorectal 
cancer death by 15-20%, save 3.8-8.29 quality adjusted life days per person and £1,890-
£2,576 of healthcare cost per life year (Hewitson et al., 2007; Tappenden et al., 2004). 
In spite of all the benefits of screening, screening uptake is low, particularly in men. 
The uptake rates of guaiac-based faecal occult blood (gFOB) test in the UK Bowel Cancer 
Screening Programme were lower in men across all three rounds of the biennial invitation 
(first round: men 53.3% vs women 61.3%; second round: men 58.0% vs women 63.7%; third 
round: men 64.1% vs women 68.2%) (Lo et al., 2015). Another study on screening uptake in 
Ontario showed a similar pattern where the uptake of screening was lower in men for 
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colorectal cancer (men 55.1% vs women 61.6%), diabetes (men 61.4% vs women 72.9%) and 
cholesterol (men 70.3% vs women 82.4%) (Borkhoff et al., 2013). A narrative scoping 
review on socio-determinants of screening uptake cites nine studies that indicated men were 
less likely to engage health screening compared to women, particularly men who are less 
educated, unemployed and from low socio-economic status (Dryden et al., 2012). However, 
this review did not provide reasons for the low screening uptake in men.  
For a screening intervention to be effective, it is important that it is tailored to the 
characteristics of the population, such as using a gendered approach. Masculinity attributes 
like avoidance of femininity, toughness and risk taking have been used to explain the 
difference in health screening behavior between men and women (Connell, 1987, 1995). The 
Madrid Statement, released by the World Health Organization (WHO) in 2001, clearly states 
that health policies must recognize that men and women have different needs, obstacles and 
opportunities in order to attain the highest standard of health (WHO, 2001 ). Experts have 
argued the importance of considering gender when developing interventions, programs and 
policies in recognition that men and women behave differently (Baker et al., 2014; Banks, 
2004; Weller & Campbell, 2009; White et al., 2011b).  
This systematic review thus aims to review the existing evidence on the barriers and 
facilitators to engaging men in health screening. We sought to identify the most commonly 
reported barriers and facilitators to health screening along with those barriers and facilitators 
that are particularly prominent in a male population (male-dominant). We hope that 
identification of these factors will help in the development of effective interventions to 
overcome these barriers and improve screening uptake in men. However, this review did not 
include studies focusing on certain male populations, such as gay and aboriginal men, as 
there are unique factors that influence their health screening behavior which deserve separate 
reviews.  
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Methods 
Eligibility Criteria 
We included qualitative, quantitative and mixed-method studies that identified men’s 
barriers or facilitators in engaging with health screening. For inclusion, a study must clearly 
differentiate the barriers or facilitators between men and women. Informants could include 
men or women patients or healthcare professionals as long as the barriers or facilitators 
discussed are those for male patients. Studies included in the review investigate men who 
have attended for screening, as well as non-attenders. Participants could be derived from any 
age group and they must be asymptomatic of the disease for the screening planned in each 
study. We excluded studies that focused on men who were gene carriers, prisoners, disabled, 
drug users, in military service, homeless, immigrants, refugees as well as aboriginal and gay 
men. These groups of men face additional barriers when seeking healthcare and they deserve 
separate reviews.  
We included all types of screening recommended by the United States Preventive 
Services Task Force (USPSTF) as well as male-specific diseases like prostate and testicular 
cancer screening (United States Preventive Services Task Force, 2016). We included studies 
on prostate cancer screening conducted before 2012 as USPSTF recommended against 
prostate cancer screening after that. Studies of barriers or facilitators of screening carried out 
as a part of a screening program were also included in this review. We excluded genetic tests 
for prostate cancer and studies that focus on screening at the emergency department. Studies 
that used an intervention to increase screening uptake, looked solely at socio-demographic 
determinants or focused on physicians’ screening practices were also excluded from this 
review.  
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Information Sources and Search 
We searched five key databases (PubMed, Embase, CINAHL via EBSCOHost, 
PsycINFO via OvidSP and Web of Science) up to 23 October 2014 to identify relevant 
articles. We combined three main concepts (men, screening, barrier/facilitator) and a 
methodological filter (qualitative/survey) using keywords and subject headings from 
respective databases in the search. The search strategy can be found in Appendix A. We only 
included articles published in English. Apart from database searching, we also sourced 
relevant articles from men’s health experts and followed up references in eligible articles. 
 
Study Selection and Appraisal  
Two researchers performed all phases of study sifting and selection independently, 
including screening of titles, abstracts and full-texts. In cases of doubt, the researchers were 
encouraged to be inclusive. Any discrepancies were resolved through discussion and 
consensus. All the included studies were appraised using the Mixed-Method Appraisal Tool 
(MMAT) which allows appraisal of the validity, reliability and generalizability of the 
quantitative, qualitative and mixed-method studies (Appendix B) (Pluye et al., 2011). It can 
also be used quickly and reliably (Pace et al., 2012). For mixed-method studies, both 
qualitative and quantitative components of the studies were appraised. The appraisal was 
conducted to report the quality of the studies and not used as a threshold for selecting studies 
for inclusion.  
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Data Extraction and Synthesis 
Data extraction and synthesis were conducted based on the ‘best fit’ framework 
synthesis method which provides ‘a means to test, reinforce and build on an existing 
published model, conceived for a potentially different but relevant population’ (Carroll et al., 
2013). Researchers can combine several frameworks if necessary and refine the framework 
by adding new themes that emerged from the data, which are not found in the initial 
framework.  
We first identified a framework on the barriers and facilitators to screening from the 
studies included in this review (Garcia-Dominic et al., 2012), supplemented by two other 
frameworks by Christy et al and Denberg et al, which focused on masculinity (avoidance of 
femininity, self-reliance, risk taking and heterosexual self-presentation) and screening 
procedure respectively, to form a more comprehensive meta-framework (Christy et al., 2014; 
Denberg et al., 2005). This meta-framework was then pilot tested by two researchers against 
ten studies before the final framework was decided.  
Two researchers extracted the data from each included paper and coded them 
deductively using the meta-framework. Data that could not fit the meta-framework were 
coded separately under a new theme in a subsequent inductive phase. Data that were unclear 
or without sufficient explanation were excluded from the analysis. 
Once data from all studies were extracted, the researchers compared the coding, 
discussed and resolved any discrepancy through consensus. The themes from the meta-
framework and the newly generated themes were combined using the thematic approach to 
produce the final framework of barriers and facilitators to health screening in men. The 
analysis including the quotations can be obtained from the researchers upon request. 
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Additional Analysis 
Besides aiming to develop the comprehensive framework of barriers and facilitators 
to health screening in men, we also sought to find out which are the most common barriers or 
facilitators by counting the number of studies that reported a barrier or facilitator and ranking 
them accordingly.  
In addition, we sought to identify the barriers and facilitators that are found 
predominantly in men, using to two methods. For qualitative studies (53 qualitative paper 
plus qualitative components of 4 mixed-method papers), criteria for deciding male-dominant 
barriers and facilitators in men appear in Appendix C. For quantitative studies, barriers and 
facilitators were considered male-dominant when there were significantly higher percentage 
of barriers or facilitators reported by men compared to women, with p < .05. 
 
Results 
Included Studies’ Characteristics 
We identified 14322 articles from five databases, contact with experts and follow up 
of references (excluding duplicates and non-journal articles) (Fig. 1). We eventually included 
103 studies in the review which consisted of 53 qualitative, 44 quantitative and 6 mixed-
method studies. In four out of six mixed-method studies, only the qualitative component of 
the study was included as the quantitative component did not meet our inclusion criteria. In 
the other two mixed-method studies both qualitative and quantitative components of the study 
were included in the analysis. 
[INSERT FIGURE 1 ABOUT HERE] 
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The characteristics of all studies and their references are presented in Appendix D. 
The studies were conducted from 1985 to 2012 and in North America (k=62), Europe (k=14), 
Africa (k=9), Oceania (k=8), Asia (k=6) and South America (k=4). Most of the studies were 
conducted in the community (k=70); few in the healthcare setting (k=19); and a small 
number in both settings (k=3). All included quantitative studies were cross-sectional studies. 
Most qualitative studies (k=53) did not report their study design and the most commonly 
reported study designs were grounded theory (k=3), phenomenology (k=2) and ethnography 
(k=1). More than half of the included studies (k=65) did not report using a theory in their 
study. Of those reported, the Health Belief Model (k=16) was the most commonly used 
theory (Champion VL, 2008). 
Among the included studies, the most commonly studied screening topics were 
prostate cancer (k=40), colorectal cancer (k=33) and HIV (k=15) and the remainder included 
sexually transmitted disease (k=4), cancer (k=4), testicular cancer (k=3), cardiovascular 
disease (k=2), skin cancer (k=1) and multiphasic examination (k=1). Twenty studies were 
conducted as a part of a screening program. Most included both attendees and non-attendees 
of screening (k=73), 11 studies included ever-screened participants; 9 studies included never-
screened participants; while 10 studies did not report.   
Out of 103 studies, 37 reported barriers, 13 facilitators and 55 both barriers and 
facilitators. Only 30 studies focused exclusively on barriers or facilitators to screening while 
73 studies focused on participants’ attitudes, beliefs and knowledge of a disease of which 
barrier to screening was only a constituent of the studies. Among the 103 studies, 47 
compared men’s barriers and facilitators to those of women while 56 only focused on men’s 
barriers. Of 24 quantitative studies comparing barriers/facilitators between men and women, 
only 13 reported p-values in their studies. 
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Barriers and Facilitators to Health Screening in Men 
Factors influencing uptake of health screening in men fall within five domains: 
individual, social, health system, healthcare professional and screening procedure (Table 1). 
The six individual factors that influence health screening uptake in men are knowledge, 
attitudes and values, fear, masculinity attributes, communication and resources. Factors 
within the social domain include influence of family and/or peers as well as stigma. For the 
health system domain, factors include accessibility to screening services, cost and insurance, 
health information, screening program or policy, men's health advocacy and quality of 
service. Healthcare professional factors include attitudes, communication, physician's gender 
and ethnicity as well as physician's recommendation. The nature of the screening procedure 
also affects men’s decisions as to whether or not to attend health screening. 
[INSERT TABLE 1 ABOUT HERE] 
There are several barriers and facilitators under each factor. The most commonly 
reported barrier to health screening across all domains is fear of being diagnosed with the 
disease and its consequences (k=52) (Table 2), followed by a perception of low risk (k=39) 
and fear of a painful screening procedure (k=37). The most commonly reported facilitators 
are perceived risk (k=31), perceived benefits of screening (k=29) and physicians’ 
recommendations to attend screening (k=24). 
[INSERT TABLE 2 ABOUT HERE] 
Table 3 shows barriers and facilitators to screening found to be dominant in 
heterosexual men based on the 57 qualitative studies. Heterosexual self-presentation (k=18), 
avoidance of femininity (k=18), self-reliance (k=10), seeking help only when disease is 
severe (k=9) and avoidance of illness (k=7) are the most commonly reported male dominant 
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barriers to screening. Partner's role (k=18), perceived risk (k=2), wanting to stay healthy to 
take care of family (k=2), non-invasive screening procedure (k=2) and physicians’ gender 
(k=2) are the most commonly reported male dominant facilitators to screening. 
[INSERT TABLE 3 ABOUT HERE] 
Table 4 shows barriers and facilitators to screening found to be dominant in men 
based on the 13 quantitative studies. Lack of time (k=6), fear of getting disease and its 
consequences (k=2), painful screening procedure (k=2) and lack of knowledge about disease 
and screening (k=2) are the barriers found to be significantly more common in men compared 
to women. For facilitators, having knowledge about disease and screening (k=1) and 
physician’s recommendation to screening (k=1) were found to be more important in men. 
However, unlike qualitative studies, masculinity factors were rarely reported in the 
quantitative studies. 
[INSERT TABLE 4 ABOUT HERE] 
 Among the five domains, the individual domain is the most commonly cited domain 
in the ten most commonly reported barriers (70.0%) as well as in qualitative (60.9%) and 
quantitative studies (62.5%) reporting male-dominant barriers (Table 5). The pattern is less 
obvious for the facilitators to health screening in men.  
[INSERT TABLE 5 ABOUT HERE] 
 
Quality Assessment 
Overall, included studies carried a moderate risk of bias. Most qualitative studies 
satisfied all assessment criteria except for criteria 4, where most studies did not report 
whether the researchers’ role might influence the outcome of the study (Appendix B). The 
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Records identified through database searching 
PubMed (k = 5906) 
EMBASE (k = 8399) 
CINAHL via EBSCOHost (k = 2513) 
PsycINFO via OvidSP (k = 1942) 
Web of Science (k = 6730) 
Total records (k = 25490) 
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Additional records identified 
through other sources 
Experts (k = 1) 
Reference mining (k = 18) 
Total records (k = 19) 
Records after duplicates and non-journal articles removed 
(k = 14322) 
Records screened 
(k = 14322) 
Full-text articles assessed 
for eligibility 
(k = 245) 
Full text articles excluded 
with reasons (k = 142) 
 Not barrier or facilitator 
to screening (k = 75) 
 Did not differentiate 
men and women (k = 67) 
 
Studies included 
(k = 103) 
Qualitative  
(k = 53) 
Records excluded based on 
eligibility criteria  
(k = 14077) 
Mixed-method 
(k = 6) 
Quantitative  
(k = 44) 
quality of quantitative studies was substantially lower as only about half of the studies 
satisfied criteria 1 (sampling strategy) and criteria 4 (response rate). These patterns were 
almost similar to the included mixed-method studies. The quality of mixed-method 
integration was moderate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. PRISMA Flow Diagram 
 13 
Discussion 
This systematic review is the first to provide a comprehensive coverage of barriers 
and facilitators to health screening in men. The barriers and facilitators extracted in this study 
are those specifically expressed by men and are different from other disease-specific 
systematic reviews, which are often not gender-specific. Masculinity and characteristics of 
the screening procedure are highlighted as two important factors among the list of barriers 
and facilitators that influence men’s decisions in taking up screening. We also identified the 
most common factors as well as those that are predominant in men. 
This review identified ‘masculinity’ as an important factor which impedes screening 
in men; this factor is seldom highlighted in the literature as a barrier to screening in men. We 
used a previously published concept of masculinity as part of our analysis framework during 
data extraction (Christy et al., 2014) and masculinity attributes such as self-reliance, 
avoidance of femininity and heterosexual self-presentation emerged as barriers to screening. 
Only ‘invincibility belief’ emerged as a new barrier under masculinity attributes from the 
studies. Interestingly, an important masculinity attribute on ‘risk taking’ did not feature 
specifically as a barrier in the studies included in this review, which could be because ‘risk 
taking’ is an attribute that is difficult to probe in an interview when men do not perceive 
themselves to be at risk. We also realized that most papers included in this review only 
discussed masculinity in the context at individual level. Nonetheless, masculinity can be 
structured in institutional practices and policies, which are not explored in this review 
(Connell, 1987, 1995; Dovel et al., 2015). Some of the individual factors, such as ‘avoiding 
and denying illness’, ‘seek help only when disease is severe’, and ‘fear of getting disease’, 
could be related to masculinity, but the authors did not explicitly report the link. Future 
studies should explore this issue. 
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Table 1. Barriers and facilitators to health screening in men synthesized from all studies.   
INDIVIDUAL DOMAIN 
FACTORS Barriers Facilitators 
Knowledge  Low risk perception (lack of symptom, no family 
history) 
 Perceived at risk (having symptoms, having family 
history, being old and following a risky event) 
 Lack of knowledge about disease and screening  Having knowledge about disease and screening 
 Feeling inferior/fear of attending screening due to 
limited education and literacy 
 
Attitudes and 
values 
o Avoiding and denying illness  
o Fatalism belief o Religious belief that a man should take care of his 
body 
o Negative attitude (lazy, procrastination or forgot) o Positive attitude (health conscious, screening as a 
routine and care for others) 
o Sceptical of the benefits of screening o Perceived benefits of screening (early intervention 
and peace of mind) 
o Seek help only when disease is severe  
o Health is not a priority o Stay healthy to take care of family 
o Not trusting the doctor or health system o Trusting the doctor or health system 
o Having other health concerns  
o Already tested or diagnosed o Already tested or diagnosed 
o Belief that illness can be healed naturally or with 
CAM 
 
Emotion - Fear  Fear of getting disease and consequence and don’t 
want to know 
 Fear of disease and consequence and want to find 
out earlier 
Masculinity  Avoidance of femininity - seeking help or talking 
about health is considered feminine or weak 
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 Heterosexual self-presentation - Undergoing DRE 
or colonoscopy may be perceived as gay 
 Heterosexual self-presentation - Use other 
screening method rather than DRE 
 Self-reliance - do not want to depend on doctors  To feel in control 
 Invincibility belief  Non-existence of machismo attributes 
Communication × Discomfort discussing issues regarding private 
part and disease 
 
× Language barrier  
Resource  Lack of time  
 Lack of income and personal insurance  Having personal insurance 
 Lack of personal transport  Having personal transportation 
SOCIAL DOMAIN 
FACTORS Barriers Facilitators 
Family and peer 
influence 
 Lack of encouragement  Encouragement and support from siblings, 
children, relative, friends and other social contact 
 Past negative health care experience  Partner's role 
 No social contact with the disease  Knowing someone with disease or died due to the 
disease 
Stigma o Concern about being stigmatized  
HEALTH SYSTEM DOMAIN 
FACTORS Barriers Facilitators 
Accessibility to 
screening services 
 Inconvenient opening hour, day and location  Convenient screening location, hour and day 
 Difficulty in making appointment  Screening without appointment required 
 Long waiting time  Short waiting time 
 Busy HCP  
Cost and insurance o Costly services o Free/reduced cost exams  
o Lack of insurance o Having insurance coverage 
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Health information  Lack of public education  More public education programs through media, 
community, school and health centre 
 Inaccurate and negative information  Church as a platform to promote health screening 
  Celebrity-led campaign and advertisement 
Screening 
programme or 
policy 
  Availability of screening program or policy 
(workplace, marriage) 
Men's health 
advocacy 
× Lack of men's health advocacy   
Quality of service  Male-unfriendly healthcare setting  Reminder by health provider 
 Lack of confidentiality  Confidentiality 
 Negative experience in health centre  Opportunistic screening 
 Limited access to treatment  Availability of treatment 
  Trained HCP 
HEALTHCARE PROFESSIONAL DOMAIN 
FACTORS Barriers Facilitators 
Attitude  Negative attitude (rude, discrimination and 
uncaring) 
 
Communication  Lack of rapport with doctor  Having good rapport with doctor 
 Lack of bilingual physicians  Availability of bilingual healthcare professional 
  Shared decision making 
Physician's gender 
and ethnicity 
o Availability of physician of the same ethnicity o Preference of female physicians to perform DRE 
Physician's 
recommendation 
 Lack of physician recommendation for screening 
tests 
 Recommended to screening 
SCREENING PROCEDURE DOMAIN 
FACTORS Barriers Facilitators 
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CAM=Complementary alternative medicine. DRE=Digital Rectal Examination. HCP=Healthcare Professional. 
The nature of 
screening 
procedure 
 Painful and uncomfortable   Less painful and discomfort procedure 
 Embarrassing procedure  
 Complication following procedure  
 Lack of privacy  
 Difficult procedure preparation   Convenience test procedure 
 Difficult sample collection  
 Impersonal procedure  
 Screening package lack comprehensiveness  
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Table 2. Ten most commonly reported barriers and facilitators to health screening in men 
from all studies. 
Barriers 
No. of 
citing 
studies 
(k=92) 
Facilitators 
No. of 
citing 
studies 
(k=68) 
Fear of getting disease and 
consequence (I) 
52 Perceived at risk - having 
symptoms, having family 
history, being old and following 
a risky event (I) 
31 
Low risk perception -  lack of 
symptom, no family history (I) 
39 Perceived benefits of screening - 
early intervention and peace of 
mind (I) 
29 
Painful and uncomfortable 
screening procedure (SP) 
37 Physician’s recommendation to 
screening (HCP) 
24 
Lack of time (I) 33 Partner's role (S) 22 
Lack of knowledge about disease 
and screening (I) 
30 More public education program 
through media, community, 
school and health centre (HS) 
18 
Embarrassing screening procedure 
(SP) 
29 Positive attitude - health 
conscious, screening as a routine 
and care for others (I) 
16 
Costly screening services (HS) 23 Knowing someone with disease or 
died due to the disease (S) 
15 
Seeking help or talking about 
health is considered feminine 
or weak (I) 
21 Encouragement and support from 
siblings, children, relative, 
friends and other social contact 
(S) 
12 
Undergoing DRE or colonoscopy 
may be perceived as gay (I) 
20 Availability of screening program 
or policy -  workplace, marriage 
(HS) 
11 
Avoiding and denying illness (I) 20 Having knowledge about disease 
and screening (I) 
11 
DRE=Digital Rectal Examination. HCP=Healthcare Professional. HS=Health System. 
I=Individual. S=Social. SP=Screening Procedure.
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Table 3. Barriers and facilitators to screening found to be dominant in men based on 57 
qualitative studies. 
FACTORS 
Number 
of studies
Barriers  
Heterosexual self-presentation - Undergoing DRE6 or colonoscopy may be 
perceived as gay (I) 
18 
Avoidance of femininity - seeking help or talking about health is considered 
feminine or weak (I) 
18 
Self-reliance - do not want to depend on doctors (I) 10 
Seek help only when disease is severe (I) 9 
Avoiding and denying illness (I)  7 
Invincibility belief (I) 6 
Embarrassing screening procedure (SP) 5 
Health is not a priority (I) 4 
Fear of getting disease and consequence (I) 4 
Lack of encouragement (S) 3 
Male-unfriendly healthcare setting (HS) 3 
Lack of privacy (SP) 3 
Lack of knowledge about disease and screening (I) 3 
Fatalism belief (I) 3 
Lack of Men's Health Advocacy (HS) 2 
Negative attitude - lazy, procrastination or forgot (I) 2 
Lack of public education (HS) 2 
Not trusting the doctor or health system (I) 2 
Low risk perception - lack of symptom, no family history (I) 2 
Difficult sample collection (SP) 1 
Complication following procedure (SP) 1 
Lack of time (I) 1 
Concern about being stigmatized (S) 1 
  
Facilitators   
Partner's role (S) 18 
Heterosexual self-presentation - Use other screening method rather than DRE6 
(SP) 
2 
Preference of female physicians to perform DRE6 (HCP) 2 
Stay healthy to take care of family (I) 2 
Perceived at risk - Having symptoms, having family history, being old and 
following a risky event (I) 
2 
Inexistence of machismo attributes (I) 1 
To feel in control (I)  1 
Opportunistic screening (HS)  1 
  7
Convenience test procedure (SP)  1 
More public education programs through media, community, school and health 
center (HS)  
1 
Recommended to attend screening (HCP)  1 
DRE=Digital Rectal Examination. HCP=Healthcare Professional. HS=Health System. 
I=Individual. S=Social. SP=Screening Procedure. 
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Table 4. Barriers and facilitators to screening which are either more dominant in men (Sig-
male), no significant difference (ns), or more dominant in women (Sig-female) based on p-
value reported in 13 quantitative papers. 
FACTORS Sig-male ns 
Sig-
female
Barriers    
Lack of time (I) 6 1 0 
Fear of getting disease and consequence (I) 2 5 2 
Painful and uncomfortable (SP) 2 2 1 
Lack of knowledge about disease and screening (I) 2 1 0 
Low risk perception - lack of symptom, no family history (I) 1 4 1 
Embarrassing procedure (SP) 1 1 3 
Complication following procedure (SP) 1 1 1 
Skeptical of the benefits of screening (I) 1 1 0 
Costly services (HS) 0 5 0 
Difficult procedure preparation (SP) 0 2 1 
Negative attitude - lazy, procrastination or forgot (I) 0 2 0 
Lack of personal transport (I) 0 2 0 
Concern about being stigmatized (S) 0 2 0 
Inconvenient opening hour, day and location (HS) 0 2 0 
Having other health concerns (I) 0 1 1 
Already tested or diagnosed (I) 0 1 1 
Lack of physician’s recommendation (HCP) 0 1 1 
Avoiding and denying illness (I) 0 1 0 
Health is not a priority (I) 0 1 0 
Lack of income and personal insurance (I) 0 1 0 
Past negative health care experience (HS) 0 1 0 
Difficulty in making appointment (HS) 0 1 0 
Lack of confidentiality (HS) 0 1 0 
HCP’s negative attitude (HCP) 0 1 0 
Difficult sample collection (SP) 0 1 0 
Lack of encouragement (S) 0 0 1 
    
Facilitators    
Having knowledge about disease and screening (I) 1 0 0 
Recommended to screening (HCP) 1 0 0 
Perceived at risk - Having symptoms, having family history, being old 
and following a risky event (I) 
0 2 1 
Availability of screening program or policy - workplace, marriage (HS) 0 2 0 
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Perceived benefits of screening - early intervention and peace of mind 
(I) 
0 1 0 
Partner's role (S)  0 1 0 
Positive attitude - Health conscious, screening as a routine and care for 
others (I) 
0 0 1 
Physician of the same gender (HCP) 0 0 1 
HCP=Healthcare Professional. HS=Health System. I=Individual. S=Social. SP=Screening 
Procedure. 
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Table 5. Summary of the ten most commonly reported and male-dominant (qualitative 
and quantitative study) barriers and facilitators to screening in men according to 
domain. 
DOMAIN Barriers  k (%) 
Facilitators 
k (%) 
Ten most commonly reported factors 10 (100%) 10 (100%) 
Individual (I) 7 (70.0%) 4 (40.0%) 
Social (S) 0 (0%) 3 (30.0%) 
Health system (HS) 1 (10.0%) 2 (20.0%) 
Healthcare professional (HCP) 0 (0%) 1 (10.0%) 
Screening procedure (SP) 2 (20.0%) 0 (0%) 
   
Male-dominant - qualitative study 23 (100%) 11 (100%) 
Individual (I) 14 (60.9%) 4 (36.4%) 
Social (S) 2 (8.7%) 1 (9.1%) 
Health system (HS) 3 (13.0%) 2 (18.2%) 
Healthcare professional (HCP) 0 (0%) 2 (18.2%) 
Screening procedure (SP) 4 (17.4%) 2 (18.2%) 
   
Male-dominant - quantitative study 8 (100%) 2 (100%) 
Individual (I) 5 (62.5%) 1 (50.0%) 
Social (S) 0 (0%) 0 (0%) 
Health system (HS) 0 (0%) 0 (0%) 
Healthcare professional (HCP) 0 (0%) 1 (50.0%) 
Screening procedure (SP) 3 (37.5%) 0 (0%) 
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‘Screening procedure’ was another unique factor that emerged from our review. 
Though many studies identify screening procedures as a barrier, such as the collection of 
faeces for bowel cancer screening, different procedures impose different levels of reluctance 
for men to present for screening (Lo et al., 2013; Vart, 2010). Procedures that are most 
commonly cited as a barrier are digital rectal examination, colonoscopy and sigmoidoscopy. 
Such procedures, involving anal penetration, have a sexual connotation and heterosexual men 
are concerned that they might be perceived as being gay. Clinicians should emphasize that 
these procedures are recommended for all men and the invasive nature of the procedure is 
necessary to detect tumors in the colon; therefore, men should not perceive the procedures as 
being gay. Unlike other factors, such as individual, social, healthcare system and healthcare 
professional factors, which are non-disease specific, screening procedure is therefore disease-
specific. More work needs to be done to overcome this barrier.  
In the included studies, the most commonly reported factor influencing men’s 
attendance at health screening relates to their knowledge regarding health and screening, 
which in turn, affects men’s perception of their own health risk and the benefits of screening. 
Some men are fearful of being diagnosed with the disease if they go for screening and, 
therefore, choose not to know about their health status. It is important for healthcare 
providers to assess and provide information on individual health risks as well as to explain 
the benefit and risks of health screening.  
We also identified several male-dominant barriers and facilitators to health screening 
in men. Masculinity attributes such as heterosexual self-presentation, avoidance of femininity 
and self-reliance are the most commonly cited male-dominant barriers to screening. It is 
important to note that masculinity attributes vary in different contexts. For example, a study 
comparing barriers to colorectal screening between two Hispanics subpopulations, Spanish 
Americans and first-generation Mexicans, in New Mexico, USA found that machismo is 
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more prominent in the latter (Getrich et al., 2012). Other barriers, such as lack of time, lack of 
knowledge, fear and screening procedure are also found more predominantly in men. For 
facilitators to screening, knowledge, partner’s role and physicians’ recommendation are the 
most important factors that motivate men to attend health screening. 
We also found that while individual factors contribute to most barriers to health 
screening in men, it is not as commonly cited as a facilitator. Thus, for a screening 
intervention targeting men to be effective, it may not be enough to just address individual 
barriers; strategies involving external factors, such as family and friends, health system, 
healthcare professional and screening procedure, may need to be incorporated to enhance 
screening uptake. A study by Holland et al has found that combining personalized letter to 
men and a reminder system by the healthcare professional resulted in a higher uptake of 
health screening as compared to sending a personalized letter alone (Holland et al., 2005). 
The uptake is even higher when the intervention was supplemented by asking the partners to 
encourage men to go for health screening. 
Another important point to note is that this systematic review only included studies 
that reported barriers and facilitators to screening from men themselves independent from 
associations with social determinants to screening uptake. Dryden et al reported that those not 
attending health checks were typically from low socio-economic status, less well educated, 
single (not married), smokers, having low self-efficacy and less likely to believe in the 
efficacy of health checks. In contrast attenders were usually White and older in age (Dryden 
et al., 2012). We did not include these social determinants because this systematic review 
aimed to find out the actual barriers and facilitators to screening in men irrespective of the 
profile of men who would or would not seek help.  
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Limitations 
This review has several limitations. This review did not include studies focusing on 
men who were gene carriers, prisoners, disabled, drug users, in military service, homeless, 
immigrants, refugees as well as aboriginal and gay men. These groups of men face additional 
barriers when seeking healthcare and deserve separate reviews, some of which have been 
published. For example, systematic reviews have been conducted on barriers to HIV testing 
in men who have sex with men (MSM) (Lorenc et al., 2011) and hepatitis C testing in people 
who inject drugs (Jones et al., 2014).  
We also did not analyze the barriers and facilitators according to age, which may 
influence how men decide to go for screening. Most of these studies included in this 
systematic review were conducted in Western countries, which may reduce their validity in 
the global South. We also identified four potentially relevant non-English articles (2 
Japanese; 1 Korean; 1 Swedish) which we did not include in this review.  
 The quality of the quantitative studies included in this review was generally poor, 
particularly in terms of questionnaire design. The questionnaires were not validated 
rigorously and factor analysis was typically not performed. Some included options represent 
compound questions (e.g., ‘costly/lack of insurance’); some responses were not meaningful 
(e.g., ‘I do not know’ and ‘I just do not want to’). Unlike the findings from qualitative 
studies, the barriers and facilitators reported in quantitative studies lack depth and hence were 
less useful for the understanding of the factors that influence men’s decision to attend 
screening. We only reported ‘commonly reported barriers’ rather than ‘the most common 
barriers’ due to the heterogeneity of study methods. Some studies permitted participants to 
choose multiple barriers while others only allowed them to choose the single most important 
barrier. Masculinity-related factors are less commonly reported because it is both difficult to 
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ask men about this and, in turn, for them to admit such issues. Many studies did not 
incorporate masculinity attributes in the design of the questionnaire. Additionally, only 13 out 
of 24 studies that compared men and women reported a p-value. Further evidence is required 
to support the male-dominant barriers or facilitators based on p-values, such as reported in 
this review. We also did not exclude lower quality studies based on the MMAT in order to 
elicit the widest possible range of barriers and facilitators.  
 
Conclusion 
This systematic review identified individual, social, health system, healthcare 
professional and screening procedure factors as important barriers and facilitators to health 
screening in men. In addition, it expands existing framework on factors influencing health 
screening uptake in men, incorporating male-dominant barriers and facilitators such as 
avoidance of femininity, heterosexual self-presentation and partner’s role into the framework. 
The findings from this review also provide a better understanding of men’s screening 
behaviour; they highlight the importance of considering the role of gender when advising 
men on health screening and when developing health policy on health prevention. The 
development of interventions to promote health screening should take into consideration the 
gender-specific barriers and facilitators identified in this review.  
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